www.fdanews.com/articles/196787-bayer-teams-up-with-canadian-institute-for-covid-19-treatments
Bayer Teams Up With Canadian Institute for COVID-19 Treatments
April 23, 2020
Bayer is partnering with Canada’s Population Health Research Institute (PHRI) to identify potential COVID-19 treatments.
The institute will evaluate different combination therapies including Bayer’s chloroquine and interferon beta-1b. It plans to enroll 6,000 patients in two studies at more than 60 sites across Ontario and internationally.
Bayer has committed $1 million dollars to the project and will supply the drugs to support the research.